LINAGLIPTIN
Phase III studies show linagliptin improved blood glucose control in Asian …
Wall Street Journal
RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from two phase III clinical studies that showed linagliptin in Asian adults, as …
READ ALL AT
http://online.wsj.com/article/PR-CO-20130622-901315.html
